
Bulk Formulations:
Ready-to-use crop protection products sold in large volumes to distributors and agro-input companies. This segment contributes recurring revenues driven by seasonal and annual farm demand.
Technical Manufacturing (B2B):
Production of core active ingredients used in pesticide formulations by other manufacturers. This backward integration enhances supply chain reliability, reduces dependency on external vendors, and lays the foundation for higher-margin operations over time.
Branded Products (B2C):
Direct sales under Mahamaya’s own brand names strengthen brand visibility and customer loyalty while improving margins through the elimination of intermediary markups.
Exports:
International operations currently contribute ~5% of revenue, with plans to increase this to 15–20% as more product registrations are secured in overseas markets including Egypt, Turkey, UAE, and the Dominican Republic.
Liquid Formulations: 13.0 lakh litres per annum
Solid Formulations (Powder/Granule): 10.4 lakh kg per annum
Liquid: 11.58 lakh litres produced (~ 89% utilization)
Solid: 11.69 lakh kg produced (~ 112% utilization)
Purchase of Equipment for existing Formulation plant
Funding capital expenditure towards setting up of a new technical manufacturing plant.
Construction of Warehouse Building and Purchase of Machinery
Funding working capital requirement of our Company
General Corporate purposes*
Integrated business model spanning formulations and technicals.
Expanding distribution network with 310+ dealers across key agricultural states.
Early mover advantage in export markets with growing product registrations.
Strong return ratios and operational efficiency.
High working capital requirements due to seasonal stocking and dealer credit cycles.
Dependence on monsoon conditions and agro-climatic variability.
Customer concentration and execution risk associated with new plant commissioning.
Exposure to imported raw materials, particularly from China.
0
52
0
Share On
Table Of Content
Company Overview
Manufacturing Capacity
Financial Performance
IPO Objectives
Tags
SME IPO
SME IPO review